swiss chems dihexa Hexamethyldisilazane for GC derivatization, LiChropur , = 99.0 GC 999-97-3 Dihexylamine, 1 X 100 mL

No COA report currently listed for this product/batch

Always follow the advice of your medical professional

Certificate of Analysis Each batch is tested by an independent third-party laboratory for: Peptide identity verification Purity analysis via HPLC (99%) Microbial contaminant screening Heavy metal analysis Residual solvent testing Description FOXO4-DRI is a D-retro-inverso peptide designed to interfere with the FOXO4-p53 interaction, supplied as a lyophilized 10mg vial

et al., Altern Ther Health Med (2024) Pilot study on BPC-157 for interstitial cystitis (private clinic) Orthopaedic & Wellness (2023) Peptide Dangers blog highlighting conflicts of interest and unknown risks USADA Spirit of Sport blog (2020): Warning to athletes about BPC-157s unapproved status usada.org